Infectious Dis.

Your Article Summary

See Latest Articles

Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection
Expert Opinion in Pharmacotherapy, 07/01/09

Iacobellis A et al. - Treatment is only recommended for a well-compensated liver cirrhosis, whereas antiviral therapy is commonly not implemented in cirrhotics with signs of liver decompensation, over the concern that the use of peginterferon and ribavirin might expose patients to severe treatment-related side effects. This review focuses on data available to support both efficacy and safety of antiviral therapy in both compensated and decompensated cirrhotic patients.

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/18/09

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/18/09

Temporal Reduction of HIV Type 1 Viral Load in Breast Milk by Single-Dose Nevirapine during Prevention of MTCT
AIDS Research and Human Retroviruses, 12/18/09

 See all of Antimicrobials

Today in Hepatitis...keeping you current

Receive free subspecialty "5-minute updates" via email

Short Communication: Transmission of Hepatitis B Viruses with Lamivudine Resistance Mutations in Newly Diagnosed HIV Individuals
AIDS Research and Human Retroviruses, 12/18/09

False Serologic Evidence for Acute Primary Toxoplasmosis During Liver Transplantation for Fulminant Hepatitis B: A Case Report
Transplantation Proceedings, 12/18/09

Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma
Journal of Viral Hepatitis, 12/17/09

 See all of Hepatitis